Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, September 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
iTAPP Declares Radiometer’s AQT90 FLEX a ‘High Impact Innovation’
Wednesday, November 06, 2013
AQT90 FLEX analyzer’s advanced technology allows rapid, laboratory standard testing.

Abcam Introduces Alexa Fluor Secondary Antibodies
Tuesday, November 05, 2013
New range offers increased choice for multi-color staining.

Olink Bioscience Introduces Proseek Multiplex CVD I 96x96
Thursday, October 31, 2013
A 92 protein biomarker panel for cardiovascular disease.

AnaSpec Introduces SensoLyte® 520 TEV Protease Assay Kit
Thursday, October 31, 2013
TEV proteinase used to remove fusion tags from recombinant proteins.

Safe, Accurate, Easy Repeat Dispensing
Wednesday, October 30, 2013
Even for difficult to handle samples.

Cobra Biologics Expands Antibody GMP Production Capacity
Tuesday, October 29, 2013
Company installs new 1000L HyClone SUB at the company’s centre of excellence.

ChromoTek Changes Distribution in the USA and Canada
Monday, October 28, 2013
ChromoTek has changed its partner to Bulldog Bio Inc.

Symphogen and Open Monoclonal Technology Announce Collaboration
Tuesday, October 15, 2013
Symphogen to employ OmniRat™ and OmniMouse™ transgenic platforms in product discovery.

Aseptika Awarded UK Patent for Home Test for Lung Infections
Monday, October 07, 2013
Aseptika announced that it has been granted a patent in the UK protecting its invention for a test for lung infections, designed to be used by patients at home and by clinicians at the bedside of patients in hospitals.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 354
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv